160 related articles for article (PubMed ID: 1936805)
41. Predictive scores in primary biliary cirrhosis: a retrospective single center analysis of 204 patients.
Weinmann A; Sattler T; Unold HP; Grambihler A; Teufel A; Koch S; Schuchmann M; Biesterfeld S; Wörns MA; Galle PR; Schulze-Bergkamen H
J Clin Gastroenterol; 2015; 49(5):438-47. PubMed ID: 25014239
[TBL] [Abstract][Full Text] [Related]
42. Combined treatment with ursodeoxycholic acid and prednisone in primary biliary cirrhosis.
Wolfhagen FH; van Buuren HR; Schalm SW
Neth J Med; 1994 Mar; 44(3):84-90. PubMed ID: 8202208
[TBL] [Abstract][Full Text] [Related]
43. Pilot study of cyclosporin A in patients with symptomatic primary biliary cirrhosis.
Minuk GY; Bohme CE; Burgess E; Hershfield NB; Kelly JK; Shaffer EA; Sutherland LR; Van Rosendaal G
Gastroenterology; 1988 Nov; 95(5):1356-63. PubMed ID: 3169499
[TBL] [Abstract][Full Text] [Related]
44. Methotrexate for primary biliary cirrhosis.
Gong Y; Gluud C
Cochrane Database Syst Rev; 2005 Jul; (3):CD004385. PubMed ID: 16034929
[TBL] [Abstract][Full Text] [Related]
45. Effects of long-term rifampicin administration in primary biliary cirrhosis.
Bachs L; Parés A; Elena M; Piera C; Rodés J
Gastroenterology; 1992 Jun; 102(6):2077-80. PubMed ID: 1587427
[TBL] [Abstract][Full Text] [Related]
46. Interstitial pneumonitis after low-dose methotrexate therapy in primary biliary cirrhosis.
Sharma A; Provenzale D; McKusick A; Kaplan MM
Gastroenterology; 1994 Jul; 107(1):266-70. PubMed ID: 8020670
[TBL] [Abstract][Full Text] [Related]
47. Histological evidence for recurrence of primary biliary cirrhosis after liver transplantation.
Balan V; Batts KP; Porayko MK; Krom RA; Ludwig J; Wiesner RH
Hepatology; 1993 Dec; 18(6):1392-8. PubMed ID: 8244263
[TBL] [Abstract][Full Text] [Related]
48. Clinical and biochemical features and therapy responses in primary biliary cirrhosis and primary biliary cirrhosis-autoimmune hepatitis overlap syndrome.
Günsar F; Akarca US; Ersöz G; Karasu Z; Yüce G; Batur Y
Hepatogastroenterology; 2002; 49(47):1195-200. PubMed ID: 12239904
[TBL] [Abstract][Full Text] [Related]
49. Prolonged treatment with ursodeoxycholic acid for primary biliary cirrhosis.
Crippa G; Cagnoni C; Castelli A; Concesi C; Girometta S; Pancotti D; Sverzellati E; Tacchini G; Pierfranceschi MG; Carrara GC
Clin Ter; 1995 May; 146(5):367-72. PubMed ID: 7796569
[TBL] [Abstract][Full Text] [Related]
50. Long-term ursodeoxycholic acid therapy for primary biliary cirrhosis: a follow-up to 12 years.
Chan CW; Gunsar F; Feudjo M; Rigamonti C; Vlachogiannakos J; Carpenter JR; Burroughs AK
Aliment Pharmacol Ther; 2005 Feb; 21(3):217-26. PubMed ID: 15691295
[TBL] [Abstract][Full Text] [Related]
51. Evidence for disease recurrence after liver transplantation for primary biliary cirrhosis. Clinical and histologic follow-up studies.
Polson RJ; Portmann B; Neuberger J; Calne RY; Williams R
Gastroenterology; 1989 Sep; 97(3):715-25. PubMed ID: 2666253
[TBL] [Abstract][Full Text] [Related]
52. Plasmapheresis exerts a long-lasting antipruritic effect in severe cholestatic itch.
Krawczyk M; Liebe R; Wasilewicz M; Wunsch E; Raszeja-Wyszomirska J; Milkiewicz P
Liver Int; 2017 May; 37(5):743-747. PubMed ID: 27778443
[TBL] [Abstract][Full Text] [Related]
53. Is ursodeoxycholic acid an effective treatment for primary biliary cirrhosis?
Poupon R; Chrétien Y; Poupon RE; Ballet F; Calmus Y; Darnis F
Lancet; 1987 Apr; 1(8537):834-6. PubMed ID: 2882236
[TBL] [Abstract][Full Text] [Related]
54. A randomized controlled trial of colchicine plus ursodiol versus methotrexate plus ursodiol in primary biliary cirrhosis: ten-year results.
Kaplan MM; Cheng S; Price LL; Bonis PA
Hepatology; 2004 Apr; 39(4):915-23. PubMed ID: 15057894
[TBL] [Abstract][Full Text] [Related]
55. A prospective trial of D-penicillamine in primary biliary cirrhosis.
Matloff DS; Alpert E; Resnick RH; Kaplan MM
N Engl J Med; 1982 Feb; 306(6):319-26. PubMed ID: 7033789
[TBL] [Abstract][Full Text] [Related]
56. [The treatment of primary biliary liver cirrhosis with ursodeoxycholic acid (preliminary report)].
Kolarski V
Vutr Boles; 1991; 30(1):65-70. PubMed ID: 1771866
[TBL] [Abstract][Full Text] [Related]
57. Progression of primary biliary cirrhosis with ursodeoxycholic acid therapy.
Perdigoto R; Wiesner RH
Gastroenterology; 1992 Apr; 102(4 Pt 1):1389-91. PubMed ID: 1551544
[TBL] [Abstract][Full Text] [Related]
58. Proceedings: Cholestyramine therapy in cholestatic liver disease of children.
Nelson R; Murphy GM; Edkins S; Nutter S; Anderson CM
Gut; 1974 Oct; 15(10):825. PubMed ID: 4434934
[No Abstract] [Full Text] [Related]
59. Methotrexate (MTX) plus ursodeoxycholic acid (UDCA) in the treatment of primary biliary cirrhosis.
Combes B; Emerson SS; Flye NL; Munoz SJ; Luketic VA; Mayo MJ; McCashland TM; Zetterman RK; Peters MG; Di Bisceglie AM; Benner KG; Kowdley KV; Carithers RL; Rosoff L; Garcia-Tsao G; Boyer JL; Boyer TD; Martinez EJ; Bass NM; Lake JR; Barnes DS; Bonacini M; Lindsay KL; Mills AS; Markin RS; Rubin R; West AB; Wheeler DE; Contos MJ; Hofmann AF
Hepatology; 2005 Nov; 42(5):1184-93. PubMed ID: 16250039
[TBL] [Abstract][Full Text] [Related]
60. [Successful treatment of primary biliary cirrhosis with cyclosporin].
Lie TS; Preissinger H
Dtsch Med Wochenschr; 1990 May; 115(18):698-702. PubMed ID: 2335133
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
